$6.93
Today
as of Jul 22, 16:48 ET
Last 30 days
Recent Press Releases & News
DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
DiaMedica Therapeutics Doses First Patients in Phase 2 Fetal Growth Restriction Trial
DiaMedica Therapeutics Announces First Patients Dosed in Phase 2 Trial of DM199 for the Treatment of Fetal Growth Restriction
Overview
52-week range
$3.48
$10
50% of range
Avg surprise (last 3)
-3.9%
Avg reaction (last 2)
+4.2%
100% positive
Latest IV / EM
63%
EM ±14.4% · $8 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 6, 2026 | Mar/2026 | $-0.19 | $-0.17 | -11.8% | -5.6% | +4.3% | earnings |
| Tue Aug 12, 2025 | Jun/2025 | $-0.18 | $-0.18 | 0.0% | — | — | earnings |
| Tue May 13, 2025 | Mar/2025 | $-0.18 | $-0.18 | 0.0% | — | +4.1% | earnings |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 11, 2026 | Jun/2026 | OTHER | -$0.19 | -$0.18 | -5.6% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-10M | — | $-9M | $-8M | $-8M | — | $-7M | $-6M |
| Net income | $-10M | — | $-9M | $-8M | $-8M | — | $-6M | $-5M |
| EPS (diluted) | — | — | — | — | — | — | — | — |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $5M | $16M | $3M | $4M | $3M | $3M | $4M | $14M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $52M | $61M | $56M | $31M | $37M | $45M | $51M | $55M |
| Total assets | $53M | $61M | $57M | $31M | $39M | $46M | $53M | $57M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | — | — | — | — | — | — | — | — |
| Total equity | $47M | $56M | $52M | $27M | $34M | $41M | $48M | $53M |